FREE shipping on all orders!
Due to its role in creating other cannabinoids, CBG, also known as cannabigerol, is called the mother of cannabinoids. Cannabigerolic acid (CBGA) includes several potential health benefits associated with CBG, including the support of anxiety, depression, and pain relief. It may not be as well-known as THC or CBD, but CBG could be the next breakout cannabinoid on the market.
Cannabigerol (CBG) is a non-intoxicating cannabinoid found in the cannabis plant. The component CBG (cannabigerol), which is regarded as the mother of all cannabinoids, is equally significant to cannabidiol (CBD), one of the most well-known medical cannabis derivatives. As the parent molecule of all other cannabinoids, CBGA (cannabigerolic acid) gives CBG considerable significance despite its small size.
What sets CBG apart from most other cannabinoids is its low concentration level in typical strains containing less than 1% CBG by weight. Because of this scarcity, most people do not realize they can benefit from this mother of all cannabinoids until they take their first bite into a high-CBD strain that just happens to have trace amounts of this wonder molecule.
Cannabigerol has many potential therapeutic benefits, including reducing inflammation and relieving pain. Unlike CBD, CBG may actually increase appetite. Research suggests that CBG may be a promising new support for many conditions, but more research is needed to confirm its efficacy.
Preliminary studies show promise for using CBG as an analgesic for arthritis and fibromyalgia, an anti-inflammatory for Crohn’s disease, ulcerative colitis, and irritable bowel syndrome; an antibiotic against MRSA; a possible option for Alzheimer’s disease; and a natural alternative to traditional antidepressants.
To date, there’s been no shortage of new or rediscovered health benefits attributed to CBG from different groups within the scientific community. In light of these developments, we will likely see a rise in interest in CBG in the coming years as researchers continue exploring its role in human health and medicine.
CBG is essential because it is the mother cannabinoid and the parent cannabinoid from which other cannabinoids are derived. It is one of only two cannabinoids with low molecular weight, enabling it to cross the blood-brain barrier easier than other cannabinoids, making it a promising natural alternative for supporting neurological symptoms.
Cannabinoids, including CBG, are being investigated for their safety and efficacy against basal-cell carcinoma (BCC)
Raphael Mechoulam, Yechiel Gaoni, and Yuval Shvo from the Weizmann Institute in Rehovot isolated CBG for the first time in 1964. During their research into the active ingredient of hashish, the scientists isolated numerous compounds from cannabis.
This research led to the discovery of CBG, among other compounds. It is the precursor to THC, CBD, CBC, and other cannabinoids. CBG is potentially an anti-inflammatory on its own merit with claimed analgesic properties, and the potential ability to protect brain cells from injury or death when used in dogs for nausea, inflammation, epilepsy, Alzheimer’s disease, arthritis, and Crohn’s disease.
Cannabigerol’s potential to kill cancer cells without harming healthy ones and reduce the growth of new blood vessels that tumors need to grow suggests it may have anti-cancer properties. Externally applied to skin cancer cells, it may also inhibit cancer cell growth without affecting healthy cells. This is all a possibility.
Breast cancer tumors were reduced in size, vascularization was decreased, and prostate cancer cells were increased in apoptosis when injected into mice. Human lung cancer cell lines were treated with it orally as part of a treatment regimen that lowered tumor proliferation rates and caused cell death.
Cannabinoids, including CBG, are being investigated for their safety and efficacy against basal-cell carcinoma (BCC). CBG is the building block from which all other cannabinoids are made, so one may argue that it deserves to be called The Mother Of Cannabinoids!
A non-intoxicating cannabinoid known as cannabigerol, or CBG, does not result in the characteristic high associated with THC. The processing of phytocannabinoids (derived from plants) and endocannabinoids are completed through numerous CB1 and CB2 receptors.
Homeostasis, a balanced state, is maintained by the receptors. Research suggests that CBG’s enormous medical potential may help support several diseases. The lack of intoxicating effects of this cannabinoid, and its numerous qualities, suggest that it may end up playing a significant role in medicine.
It has been demonstrated to provide a variety of therapeutic advantages, including the following:
Animal studies using mice have proven CBG to have anti-inflammatory characteristics that reduce the symptoms of Crohn’s disease.
The study shows CBG protects neuroprotective properties that may be very helpful for those with Huntington’s disease, a hereditary and degenerative brain ailment.
Cannabigerol may be able to treat bladder dysfunction diseases and prevent them from occurring. Evidence suggests that CBG significantly improved bladder contractions in both rats and human.
In another study conducted by the Department of Biological Sciences, University of Lethbridge, Lethbridge, AB, Canada, CBG slowed down the growth of cancer cells, primarily those of colorectal cancer, which is a significant advancement in the fight against this illness.
CBG may be a valuable ally for patients with glaucoma, a condition that damages the optic nerve. Endocannabinoid receptors are found in the eye, and CBG may have nerve fiber and intraocular pressure-lowering effects. CBG may also be a powerful antibacterial agent, especially when administered topically to treat skin infections.
Despite sharing medicinal qualities, CBG and CBD do differ. The chemical structures of the two cannabinoids, for instance, differ. This indicates that the configuration of carbon, hydrogen, and oxygen has changed. Bioavailability and receptor binding of the cannabinoid are both influenced by its molecular structure.
How CBG and CBD activate receptors is also distinct; the 5-HT1A serotonin receptor interactions with CBG and CBD were examined.
CBD may have potent anti-nausea properties, acting like an agonist, and CBG acts as an antagonist at that receptor. Although the two cannabinoids are similar, they have different actions on this particular receptor when attached to the location.
The way that CBG and CBD increase the appetite is different. It was discovered that CBG induced mice to consume twice as much food as usual. A study on CBD revealed that it lowers overall food intake.
I hope you feel more assured now that you know how CBG may help you. The CBD+CBG Energy & Focus Gel Capsules from CBD ReThink are made with tried-and-true components for game-changing support in energy and sharper focus. Our CBD+CBG Energy & Focus Gel Capsules include CBD and CBG (cannabigerol), an exceptional cannabinoid with distinctive biological effects.
You may achieve the ideal energy boost without the crash or side effects associated with energy shots and coffee by combining CBD, CBG, B12, and caffeine. Our products are made using hemp cultivated in the United States in a cGMP facility. An independent third-party laboratory checks the raw ingredients and final product for safety and purity.
If you need any more information or assistance, please reach out, we’re always here for you!
A glowing complexion doesn’t happen by chance — it’s the result of choosing the right products to nurture and protect your skin. But with so many options available, picking the right day cream can feel overwhelming. Where do you even begin?
A glowing complexion doesn’t happen by chance — it’s the result of choosing the right products to nurture and protect your skin. But with so many options available, picking the right day cream can feel overwhelming. Where do you even begin?
